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Abstract 
Programmed Cell Death 5 (PDCD5) was originally 
identified as an apoptosis-accelerating molecule 
that was widely expressed and well-conserved in 
the process of evolution.  
It has significant homology to the corresponding 
proteins of species ranging from yeast to mice gene. 
PDCD5 can accelerate apoptosis in different type of 
cells in response to different stimuli, and can also 
induce different types of cell death, including 
paraptosis-like cell death. In cells undergoing 
apoptosis, PDCD5 rapidly translocates from the 
cytoplasm to the nucleus before phosphatidylserine 
is externalized and genomic DNA undergoes 
fragmentation.  
PDCD5 interacts with TIP60 and TP53 and plays 
an important positive role in TIP60-P53 signaling 
pathway.  
PDCD5 also participates in immune regulation 
through regulating the level of FOXP3 protein and 
percentage of regulatory T cells.  
Dysfunction of PDCD5 was associated in many 
diseases including different tumors, rheumatoid 
arthritis and presbycusis, etc. 
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Identity 
Other names: TFAR19 
HGNC (Hugo): PDCD5 
Location: 19q13.11 
Local order: Orientation: Plus Strand. 
DNA/RNA 
Description 
The PDCD5 gene, with 6286 bases in length, 
consists of 6 exons and 5 intervening introns. 
Transcription 
The PDCD5 gene encodes a 604 bp mRNA 
transcript. Transcription site is located 75 bp 
upstream the first ATG of the PDCD5 ORF. The 
translation start site is located in exon 1. 
Pseudogene 
Pseudogenes have been identified on chromosomes 
12p12.3 and 5q13.2. 
Protein 
Description 
PDCD5 protein is composed of 125 amino acids, 
with a calculated molecular mass of 14.285 kDa. In 
the protein sequence exist six phosphorylation sites, 
including a cAMP and cGMP depended protein 
kinase phosphorylation site (Ser100), 4 PKC 
phosphorylation sites (Ser51, Ser84, Thr103, 
Thr108), and a casein kinase 2 (CK2) 
phosphorylation site (Ser118) (Saivi et al., 2009). 
Five of the phosphorylation sites are located in the 
C-terminal region. 
Expression 
PDCD5 is widely expressed in different organs and 
different stages. Decreased expression of PDCD5 
has been detected in various human tumors, such as 
lung cancer, gastric cancer, chronic myelogenous 
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leukemia, prostate cancer, chondrosarcoma and epithelial ovarian carcinomas.  
 
The DNA sequence of PDCD5. 
 
 
The abnormal expression of PDCD5 is also 
involved in some autoimmune diseases and 
inflammatory processes, such as lupus nephritis, 
osteoarthritis, rheumatoid arthritis, hepatitis, sepsis 
and bronchial asthma. In the patients with 
rheumatoid arthritis, the levels of PDCD5 in serum 
and synovial fluid are inversely associated with the 
expression of inflammatory cytokines IL-17 and 
TNF- α and disease activity. 
Localisation 
PDCD5 protein has been reported to be localized 
mainly in the cytoplasm and nucleus, and 
translocated to the nucleus during apoptosis (Chen 
et al., 2006). 
Function 
PDCD5 can promote apoptosis in different cell 
types in response to various stimuli. PDCD5 
interacts with the histone acetyltransferase TIP60 
and the transcription factor TP53 to promote 
apoptosis (Xu et al., 2009; Xu et al., 2012). PDCD5 
can also interact with other molecules such as NF-
kB p65 and CCT in which participate in the 
regulation of cell apoptosis. It also associates with 
TAJ/TROY-induced paraptosis-like cell death 
(Wang et al., 2004), focal cerebral ischemic 
reperfusion injury (Jiang et al., 2014), virus 
infections (Li et al., 2014) and cardiac remodeling 
(An et al., 2012). PDCD5 negatively regulates 
autoimmunity by enhancing the level of FOXP3 
protein, upregulating FOXP3+ regulatory T cells 
and suppressing Th17 and Th1 responses (Xiao et 
al., 2013). 
Homology 
PDCD5 gene is highly-conserved among species 
(from yeast to human). 
Mutations 
Germinal 
No data. 
Somatic 
The promoter with -27G/-11A is associated with 
reduced PDCD5 promoter activity and increased 
susceptibility to chronic myelogenous leukemia 
(Ma et al., 2005).  
A C/G polymorphism (rs1862214) located 35 kb 
upstream of the PDCD5 gene was associated with 
lung cancer susceptibility (Spinola et al., 2006). 
Implicated in 
Various cancers 
Note 
Reduced PDCD5 expression has been found in a 
few types of human tumors and is also associated 
with the high progression and poor prognosis. 
Decreased expression of PDCD5 has been reported 
in various human tumors, such as gastric cancer 
(Gao et al., 2012), brain tumors (Li et al., 2008), 
bone tumor (Chen et al., 2010a), ovarian 
carcinomas (Zhang et al., 2011), leukemia (Ruan et 
al., 2006), renal tumor (Tan et al., 2006), lung 
cancer (Spinola et al., 2006), prostate cancer (Du et 
al., 2009), hepatocellular cancer (Fu et al., 2013), 
laryngeal cancer (Xu et al., 2013), oral squamous 
cell carcinoma (Zhao et al., 2013) and cervical 
cancer (Liu et al., 2013).  
PDCD5 expression predicts a favorable outcome in 
patients with hepatocellular carcinoma, epithelial 
ovarian carcinomas, chondrosarcoma. 
PDCD5 may make significance to inhibit tumor 
malignant transformation and progress. 
Recombinant human PDCD5 (rhPDCD5) has been 
shown to enter a variety of cells by clathrin-
independent endocytosis and exert biological 
activities.  
RhPDCD5 could enhance cell death of tumor cells 
and enhance the sensitivity to chemotherapeutic, 
such as cisplatin (Chen et al., 2010b; Shi et al., 
2010; Wang et al., 2013c). 
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Rheumatoid arthritis 
PDCD5 is associated with rheumatoid arthritis and 
osteoarthritis, which can regulate the apoptosis of 
synoviocytes and chondrocytes (Wang et al., 2007). 
The levels of PDCD5 in serum, synovial fluid and 
cartilage are higher in RA and OA than healthy 
control, which are negatively correlated with IL-17 
or TNF-α levels (Wang et al., 2013a). The 
expression of PDCD5 may be down regulated by 
Insulin-like growth factor 1 (Yi et al., 2013). 
Recombinant human PDCD5 has an anti-
inflammatory effect in collagen-induced arthritis 
(CIA) rats (Xiao et al., 2014). 
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